Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Bousquet

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Pharmacology & Therapeutics|November 27, 2012
Murine models for pharmacological studies of the metabolic syndromeLyne Fellmann, Alessandro R Nascimento, Eduardo Tibiriça, et al.
Neuropharmacology|January 16, 2003
Nitric oxide discriminates the sites and mechanisms of action of centrally acting anti-hypertensive drugs in rabbitsGuata Yoro Sy, Véronique Bruban, Pascal Bousquet, et al.
JAMA Pediatrics|May 10, 2016
Expression of Circulating Muscarinic Receptors in Infants With Severe Idiopathic Life-Threatening EventsChris Adamopoulos, Hugues Greney, Maxime Beutelstetter, et al.
Pharmacological Reviews|December 11, 2019
Imidazoline Receptor System: The Past, the Present, and the FuturePascal Bousquet, Alan Hudson, Jesús A García-Sevilla, et al.
Endocrinology|February 27, 2010
The purinergic P2Y1 receptor supports leptin secretion in adipose tissueMarc-André Laplante, Laurent Monassier, Monique Freund, et al.
Journal of Cardiovascular Pharmacology|December 31, 2009
Microvascular effects of centrally acting antihypertensive drugs in spontaneously hypertensive ratsAlessandro Rodrigues Nascimento, Marcos Adriano Lessa, Bruno Sabino, et al.
International Journal of Obesity (2005)|March 3, 2021
Protective effects of the imidazoline-like drug lnp599 in a marmoset model of obesity-induced metabolic disordersMaud Weiss, Lyne Fellmann, Pierrick Regnard, et al.
Journal of Hypertension|April 10, 2008
G-protein inwardly rectifying potassium channels are involved in the hypotensive effect of I1-imidazoline receptor selective ligandsGuata Yoro Sy, Dragan Urosevic, Lyne Fellmann, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2008
Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in miceLaurent Monassier, Marc-André Laplante, Fabrice Jaffré, et al.
Journal of Cardiovascular Pharmacology|April 29, 2022
Nischarin Is Not the Functional I1 Imidazoline Receptor Involved in Blood Pressure RegulationAlizée Arnoux, Gaëlle Aubertin, Sylvia Da Silva, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Pharmacology & Therapeutics|November 27, 2012
Murine models for pharmacological studies of the metabolic syndromeLyne Fellmann, Alessandro R Nascimento, Eduardo Tibiriça, et al.
Neuropharmacology|January 16, 2003
Nitric oxide discriminates the sites and mechanisms of action of centrally acting anti-hypertensive drugs in rabbitsGuata Yoro Sy, Véronique Bruban, Pascal Bousquet, et al.
JAMA Pediatrics|May 10, 2016
Expression of Circulating Muscarinic Receptors in Infants With Severe Idiopathic Life-Threatening EventsChris Adamopoulos, Hugues Greney, Maxime Beutelstetter, et al.
Pharmacological Reviews|December 11, 2019
Imidazoline Receptor System: The Past, the Present, and the FuturePascal Bousquet, Alan Hudson, Jesús A García-Sevilla, et al.
Endocrinology|February 27, 2010
The purinergic P2Y1 receptor supports leptin secretion in adipose tissueMarc-André Laplante, Laurent Monassier, Monique Freund, et al.
Journal of Cardiovascular Pharmacology|December 31, 2009
Microvascular effects of centrally acting antihypertensive drugs in spontaneously hypertensive ratsAlessandro Rodrigues Nascimento, Marcos Adriano Lessa, Bruno Sabino, et al.
International Journal of Obesity (2005)|March 3, 2021
Protective effects of the imidazoline-like drug lnp599 in a marmoset model of obesity-induced metabolic disordersMaud Weiss, Lyne Fellmann, Pierrick Regnard, et al.
Journal of Hypertension|April 10, 2008
G-protein inwardly rectifying potassium channels are involved in the hypotensive effect of I1-imidazoline receptor selective ligandsGuata Yoro Sy, Dragan Urosevic, Lyne Fellmann, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2008
Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in miceLaurent Monassier, Marc-André Laplante, Fabrice Jaffré, et al.
Journal of Cardiovascular Pharmacology|April 29, 2022
Nischarin Is Not the Functional I1 Imidazoline Receptor Involved in Blood Pressure RegulationAlizée Arnoux, Gaëlle Aubertin, Sylvia Da Silva, et al.
Pageof 5